PureTech Ventures
VC · Boston · United States
Etapas
Región de inversión
Industrias
Perfil
PureTech Ventures is a venture capital firm based in Boston, focusing on life sciences and health technology. Founded as a part of PureTech Health, the firm is led by CEO Robert Lyne, who has a background in UK-listed life science innovation. The team has extensive experience in research and development, having supported numerous regulatory approvals and strategic transactions. PureTech Ventures is characterized by its strong R&D engine and collaborative approach, partnering with scientific experts to co-invent and advance novel intellectual property. The firm invests in various sectors within life sciences, with a focus on biotechnology and medical devices. They typically target companies at various stages of development, from early to late stage, though specifics on check sizes are not publicly detailed. PureTech Ventures collaborates internationally but is primarily concentrated in North America. As a component of PureTech Health, the firm benefits from extensive research capabilities and financial backing. Notable portfolio companies include Celea Therapeutics, known for its innovative approaches to treating idiopathic pulmonary fibrosis. Other investments reflect a similar focus on transformative healthcare solutions, underscoring PureTech Ventures' strategic emphasis on high-impact technologies.
Contactos (2)
| Nombre | Cargo | Teléfono | ||
|---|---|---|---|---|
| Co-founder & President | — | — | — | |
| Chief Executive Officer | — | — | — |
El nombre, email y teléfono se muestran en sombra. Suscribite para verlos completos.